Last verified · v1.0
Calculator · health
Swiss Cheese Coronavirus Risk Calculator
Calculate residual COVID-19 infection risk by stacking 7 protective layers: vaccination, masking, ventilation, distancing, testing, and hand hygiene.
Inputs
Residual Infection Risk
—
Explain my result
Get a plain-English breakdown of your result with practical next steps.
The formula
How the
result is
computed.
What Is the Swiss Cheese Coronavirus Risk Calculator?
The Swiss Cheese Coronavirus Risk Calculator translates the layered-defense framework of pandemic risk reduction into a single, quantifiable probability. Virologist Ian Mackay popularized the Swiss Cheese Model during the COVID-19 pandemic: each protective measure acts like a slice of cheese, riddled with imperfect holes, but stacking multiple slices closes nearly every gap. This calculator applies that framework mathematically, producing a residual infection risk estimate after every active layer of protection is factored in.
The Core Formula
The calculator uses a multiplicative risk-reduction model derived from layered-controls theory in occupational health:
Rresidual = Rbaseline × ∏i=1n (1 − ei)
- Rresidual — Final estimated probability of infection after all protective layers are applied.
- Rbaseline — Estimated exposure probability with no protective measures, based on local community prevalence and contact intensity.
- ei — Fractional effectiveness of each protective layer i, expressed as a decimal between 0 (no effect) and 1 (perfect protection).
- ∏ — The product operator, multiplying together the pass-through fraction of every active layer.
Each term (1 − ei) represents the proportion of risk that penetrates a given layer. Multiplying all these fractions by the baseline risk yields the residual risk that remains when every defense operates simultaneously. This approach is consistent with the hierarchy-of-controls framework codified in the OSHA COVID-19 Emergency Temporary Standard and elaborated in the Federal Register occupational exposure rule.
Variable Definitions and Effectiveness Ranges
Baseline Exposure Risk
This is the probability of infection under zero-protection conditions, shaped by local case rates (cases per 100,000 per week), exposure duration, and contact intensity. High-prevalence settings (>200 cases/100k/week) combined with prolonged close indoor contact can push baseline risk above 10% for a single event.
Vaccination Status
Vaccination reduces both susceptibility and transmissibility. Primary mRNA series vaccination demonstrated 70–90% effectiveness against symptomatic infection in pre-Omicron trials. Updated boosters restore effectiveness against circulating variants. Per CDC guidance, staying current with recommended doses maintains the highest protective benefit. In this model, a current booster corresponds to an effectiveness coefficient of approximately 0.70–0.85.
Mask Type
NIOSH-approved N95 respirators filter at least 95% of airborne particles and deliver measured source-control effectiveness near 85–92% when properly fitted. KN95 and KF94 masks perform comparably under laboratory conditions. Surgical masks offer roughly 50–60% effectiveness. Cloth masks provide approximately 30–50% protection and represent the weakest masking layer in this model.
Ventilation and Setting
Outdoor settings dilute respiratory aerosols by orders of magnitude, conferring up to 80% risk reduction over stagnant indoor air. ASHRAE-compliant mechanical ventilation with HEPA filtration or high air-change rates (≥6 ACH) reduces indoor transmission risk by 50–70%. The NIH/PMC Swiss Cheese Model study identifies ventilation as one of the highest-leverage environmental controls precisely because aerosol concentration drops with every additional air change.
Physical Distancing
Maintaining 6 feet (1.8 m) or more from others reduces exposure to large respiratory droplets and lowers aerosol concentration through proximity reduction. Epidemiological studies supporting the Federal Register occupational standard associate consistent 6-foot distancing with approximately 70–80% reduction in close-contact transmission risk compared with standing within 3 feet.
Recent Negative Testing of Contacts
A negative rapid antigen test within 24 hours or a negative PCR result within 48 hours of an exposure event substantially lowers the probability that contacts are actively shedding virus. Rapid antigen tests exhibit 85–98% sensitivity during peak viral shedding. Pre-exposure screening of all attendees can reduce residual risk by 70–90% depending on test type and timing relative to exposure.
Hand Hygiene
Although SARS-CoV-2 spreads primarily via respiratory aerosols, fomite transmission on contaminated surfaces contributes to overall exposure. Frequent handwashing with soap and water for at least 20 seconds, or application of 60%+ alcohol-based hand sanitizer, limits fomite-mediated risk. The NIH/PMC Swiss Cheese Model analysis categorizes hand hygiene as an additive behavioral layer with approximately 20–40% effectiveness against the fomite transmission pathway.
Worked Example
Consider a booster-vaccinated individual (e = 0.78) attending an indoor concert while wearing an N95 respirator (e = 0.88), in a venue with HEPA-filtered mechanical ventilation (e = 0.62), maintaining 6-foot distancing (e = 0.75), where all attendees tested negative the prior day (e = 0.82), and practicing consistent hand hygiene (e = 0.28). Community prevalence sets Rbaseline = 0.08 (8%).
Rresidual = 0.08 × (1−0.78) × (1−0.88) × (1−0.62) × (1−0.75) × (1−0.82) × (1−0.28)
= 0.08 × 0.22 × 0.12 × 0.38 × 0.25 × 0.18 × 0.72 ≈ 0.0000255 (0.00255%)
An 8% baseline risk falls to roughly 1-in-40,000 when all seven layers are active simultaneously, demonstrating why stacking measures delivers protection no single intervention can match.
Limitations
Effectiveness coefficients are population-level averages. Individual results vary with biological susceptibility, viral load at exposure, behavioral compliance, and variant-specific escape. This tool serves educational and planning purposes and does not replace professional medical advice or real-time public health guidance.
Reference